Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Viking Therapeutics, Inc. (VKTX).

In contrast, shares of Viking Therapeutics (NASDAQ: VKTX) are up a modest 3.3%. And why? As CNBC reports today, the Biden administration is using its last few days in office to add 15 prescription ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

Viking Therapeutics (NASDAQ: VKTX) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's share price eroded by 24% in December, primarily on the back of a ...

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $32.87, denoting a +0.67% change from the preceding trading day.

In the latest market close, Viking Therapeutics, Inc. (VKTX ... At the same time, the Dow added 0.86%, and the tech-heavy Nasdaq lost 0.38%. Coming into today, shares of the company had lost ...

The most recent trading session ended with Viking Therapeutics, Inc. (VKTX ... while the tech-heavy Nasdaq depreciated by 0.9%. The company's stock has dropped by 22.79% in the past month ...

On the other hand, the Dow registered a loss of 0.06%, and the technology-centric Nasdaq increased by 1.24%. The upcoming earnings release of Viking Therapeutics, Inc. will be of great interest to ...

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at ...

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Viking Therapeutics, Inc. (VKTX).